BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12177807)

  • 1. Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells.
    Gu X; Niu J; Dorahy DJ; Scott R; Agrez MV
    Br J Cancer; 2002 Jul; 87(3):348-51. PubMed ID: 12177807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells.
    Agrez M; Gu X; Turton J; Meldrum C; Niu J; Antalis T; Howard EW
    Int J Cancer; 1999 Mar; 81(1):90-7. PubMed ID: 10077158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.
    Ahmed N; Pansino F; Clyde R; Murthi P; Quinn MA; Rice GE; Agrez MV; Mok S; Baker MS
    Carcinogenesis; 2002 Feb; 23(2):237-44. PubMed ID: 11872628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit.
    Niu J; Dorahy DJ; Gu X; Scott RJ; Draganic B; Ahmed N; Agrez MV
    Int J Cancer; 2002 Jun; 99(4):529-37. PubMed ID: 11992542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct integrin alphavbeta6-ERK binding: implications for tumour growth.
    Ahmed N; Niu J; Dorahy DJ; Gu X; Andrews S; Meldrum CJ; Scott RJ; Baker MS; Macreadie IG; Agrez MV
    Oncogene; 2002 Feb; 21(9):1370-80. PubMed ID: 11857080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of the β6 gene to suppress degradation of ECM via inactivation of the MAPK pathway in breast adenocarcinoma cells.
    Zhang Y; Wei L; Yu J; Li G; Zhang X; Wang A; He Y; Li H; Yin D
    Oncol Rep; 2014 Nov; 32(5):1787-95. PubMed ID: 25176506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin-mediated signalling of gelatinase B secretion in colon cancer cells.
    Niu J; Gu X; Turton J; Meldrum C; Howard EW; Agrez M
    Biochem Biophys Res Commun; 1998 Aug; 249(1):287-91. PubMed ID: 9705874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer.
    Liu S; Wang J; Niu W; Liu E; Wang J; Peng C; Lin P; Wang B; Khan AQ; Gao H; Liang B; Shahbaz M; Niu J
    Cancer Lett; 2013 Jan; 328(2):325-34. PubMed ID: 23073477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6.
    Wang J; Wu J; Hong J; Chen R; Xu K; Niu W; Peng C; Liu E; Wang J; Liu S; Agrez M; Niu J
    Cancer Lett; 2011 Dec; 311(1):38-47. PubMed ID: 21741165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
    Ahmed N; Pansino F; Baker M; Rice G; Quinn M
    J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells.
    Thomas GJ; Hart IR; Speight PM; Marshall JF
    Br J Cancer; 2002 Oct; 87(8):859-67. PubMed ID: 12373600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains.
    Yokosaki Y; Monis H; Chen J; Sheppard D
    J Biol Chem; 1996 Sep; 271(39):24144-50. PubMed ID: 8798654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver.
    Yang GY; Xu KS; Pan ZQ; Zhang ZY; Mi YT; Wang JS; Chen R; Niu J
    Cancer Sci; 2008 May; 99(5):879-87. PubMed ID: 18294287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.
    Karadag A; Fedarko NS; Fisher LW
    Cancer Res; 2005 Dec; 65(24):11545-52. PubMed ID: 16357164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protrusive phase and full development of integrin-dependent adhesions in colon epithelial cells require FAK- and ERK-mediated actin spike formation: deregulation in cancer cells.
    Brunton VG; Fincham VJ; McLean GW; Winder SJ; Paraskeva C; Marshall JF; Frame MC
    Neoplasia; 2001; 3(3):215-26. PubMed ID: 11494115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer.
    Li W; Liu Z; Zhao C; Zhai L
    Oncol Rep; 2015 Sep; 34(3):1345-52. PubMed ID: 26134759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression.
    Niu J; Gu X; Ahmed N; Andrews S; Turton J; Bates R; Agrez M
    Int J Cancer; 2001 Apr; 92(1):40-8. PubMed ID: 11279604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin β6 can be translationally regulated by eukaryotic initiation factor 4E: Contributing to colonic tumor malignancy.
    Enyu L; Zhengchuan N; Jiayong W; Benjia L; Qi S; Ruixi Q; Cheng P; Khan AQ; Wei S; Jun N
    Tumour Biol; 2015 Aug; 36(8):6541-50. PubMed ID: 25982998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alphavbeta5/beta6 integrin suppression leads to a stimulation of alpha2beta1 dependent cell migration resistant to PI3K/Akt inhibition.
    Defilles C; Lissitzky JC; Montero MP; André F; Prévot C; Delamarre E; Marrakchi N; Luis J; Rigot V
    Exp Cell Res; 2009 Jul; 315(11):1840-9. PubMed ID: 19328197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion.
    Van Slambrouck S; Grijelmo C; De Wever O; Bruyneel E; Emami S; Gespach C; Steelant WF
    Int J Oncol; 2007 Dec; 31(6):1501-8. PubMed ID: 17982677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.